Apr 28, 2011

New FDA Terbutaline Warnings

So I found out some very interesting information. I often find myself looking on the internet for information relating to my symptoms. And I just so happened to have googled: Terbutaline + FDA and found some pretty serious stuff!

FDA Drug Safety Communication: New Warnings against use of Terbutaline to treat preterm labor. 2-27-2011

http://www.fda.gov/Drugs/DrugSafety/ucm243539.htm

Additional Information for Patients:
Be aware that serious side effects, including maternal heart problems and death, have been reported after prolonged use of terbutaline to manage preterm labor
Be aware that death and serious adverse reactions including increased heart rate, transient hyperglycemia, hypokalemia, cardiac arrythmias, pulmonary edema, and myocardial ischemia have been reported after prolonged administration of oral or injectable terbutaline to pregnant women.
Treatment with Terbutaline administered by injection or by continuous infusion pump should not be used beyond 48 to 72 hours. In particular injectable terbutaline should not be used in the outpatient or the home setting.
There are certain obstetrical conditions where the healthcare professional may decide that the benefits of terbutaline injection for an individual patient in a hospital setting clearly outweighs the risk.
Oral terbutaline is contraindicated for the treatment or prevention of preterm labor.


Good to know and share....

Always good to be informed......